S Carturan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S Carturan

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Leukemia|November 5, 2005

The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistanceD Cilloni, F Messa, F Arruga, et al.

American Journal of Hematology|September 9, 2006

NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell lineA Morotti, D Cilloni, M Pautasso, et al.

Leukemia|April 11, 2008

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutationsD Cilloni, F Messa, V Rosso, et al.

Tissue Antigens|April 3, 2008

HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosusR Rizzo, T V F Hviid, M Govoni, et al.

Leukemia|January 15, 2010

WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivityD Cilloni, S Carturan, C Maffè, et al.

Leukemia|May 18, 2007

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Leukemia|November 5, 2005

The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistanceD Cilloni, F Messa, F Arruga, et al.

American Journal of Hematology|September 9, 2006

NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell lineA Morotti, D Cilloni, M Pautasso, et al.

Leukemia|April 11, 2008

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutationsD Cilloni, F Messa, V Rosso, et al.

Tissue Antigens|April 3, 2008

HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosusR Rizzo, T V F Hviid, M Govoni, et al.

Leukemia|January 15, 2010

WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivityD Cilloni, S Carturan, C Maffè, et al.

Leukemia|May 18, 2007

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.

Pageof 2